SynBioBeta 2026 Speaker

Victor Gotho

Enzyva

CEO

Enzyva: Precision Engineering for the Bio-EconomyThe bio-revolution is no longer about discovery; it is about performance and predictability. At Enzyva, we have moved past the experimental phase of synthetic biology to deliver high-impact, scalable solutions for the most demanding industries.The Problem: The Industrial BottleneckMost biological innovations fail when they hit the real world. They are too unstable, too inconsistent, or simply too expensive to scale. The market is tired of "lab-scale" promises that canโ€™t meet industrial-grade KPIs.The Solution: The Enzyva EdgeEnzyva has developed a proprietary platform that optimizes biological systems for maximum output and reliability. We specialize in:Predictive Optimization: Taking the guesswork out of bio-based production.Industrial Robustness: Ensuring our solutions perform under real-world pressures.Operational Speed: Reducing the time between concept and commercialization.Strategic Leadership & ExpertiseMy expertise lies in operational strategy and the commercialization of complex technologies. I focus on the "Bio-Business" bridge. While our technical team pushes the boundaries of what's possible, my role is to ensure those breakthroughs are economically viable, scalable, and ready for market integration. I specialize in navigating the transition from a technical proof-of-concept to a robust, revenue-generating operation.Why Enzyva?We are here at SynBioBeta to connect with partners who demand more than just innovationโ€”they demand results. We are looking for collaborators ready to integrate Enzyvaโ€™s superior biological performance into their core value chain.Enzyva: Biology at the speed of business.

Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor splatter with lime dots
Blue watercolor splatter
var(--variable-xyeEn_rYM)

Reagan

Jarvis

Anocca AB

CEO, Co-founder

var(--variable-xyeEn_rYM)

Alex

Rives

CZI Biohub

Head of Science

var(--variable-xyeEn_rYM)

Karenโ€ฏ

Akinsanya

Schrodinger

President, R&D โ€“ Therapeutics

var(--variable-xyeEn_rYM)

Christopher

Arendt

Takeda

CSO, Head of Research

var(--variable-xyeEn_rYM)

Stef

van Grieken

Cradle

CEO

var(--variable-xyeEn_rYM)

Michael

Koeris

DARPA

Director, BTO

var(--variable-xyeEn_rYM)

Jennifer

Dionne

Pumpkinseed

CEO

var(--variable-xyeEn_rYM)

Daniyal

Hussain

GSK

Exec. Dir., Tech BD

var(--variable-xyeEn_rYM)

Cynthia

Hong

Novartis

Dir., Search & Evaluation

var(--variable-xyeEn_rYM)

Sarah Lynn

Tao

CSL Behring

Sr. Dir., S&E; Ig TA & Tech Lead

Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure

SynBioBeta 2027 May 3-6, San Jose, California